PropertyValue
?:abstract
  • Patients with novel coronavirus disease 2019 (COVID-19) experience various degrees of liver function abnormalities. Liver injury requires extensive work-up and continuous surveillance and can be multifactorial and heterogeneous in nature. In the context of COVID-19, clinicians will have to determine whether liver injury is related to an underlying liver disease, drugs used for the treatment of COVID-19, direct effect of the virus, or a complicated disease course. Recent studies proposed several theories on potential mechanisms of liver injury in these patients. This review summarizes current evidence related to hepatobiliary complications in COVID-19, provides an overview of the available case series and critically elucidates the proposed mechanisms and provides recommendations for clinicians.
?:creator
?:doi
?:doi
  • 10.1177/2050640620924157
?:journal
  • United_European_Gastroenterol_J
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/ad87636808fcce62fd2fe5f50c968b604dc21197.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7268949.xml.json
?:pmcid
?:pmid
?:pmid
  • 32450787.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Liver injury in COVID-19: The current evidence
?:type
?:year
  • 2020-05-26

Metadata

Anon_0  
expand all